EANM guideline on quality risk management for radiopharmaceuticals

Eur J Nucl Med Mol Imaging. 2022 Aug;49(10):3353-3364. doi: 10.1007/s00259-022-05738-4. Epub 2022 Apr 7.

Abstract

This document is intended as a supplement to the EANM "Guidelines on current Good Radiopharmacy Practice (cGRPP)" issued by the Radiopharmacy Committee of the EANM (Gillings et al. in EJNMMI Radiopharm Chem. 6:8, 2021). The aim of the EANM Radiopharmacy Committee is to provide a document that describes how to manage risks associated with small-scale "in-house" preparation of radiopharmaceuticals, not intended for commercial purposes or distribution.

Keywords: Quality assurance; Radiopharmaceuticals; Risk assessment.

MeSH terms

  • Humans
  • Nuclear Medicine*
  • Radiopharmaceuticals* / adverse effects
  • Risk Management

Substances

  • Radiopharmaceuticals